NEUROCHLORE
Neurochlore to develop and test novel applications for its therapeutic agent. Indeed, Neurochlore has an international patent in the use of a diuretic in the treatment of autism spectrum disorders and another syndrome associated with autism.
NEUROCHLORE
Industry:
Clinical Trials Medical Neuroscience
Founded:
2011-01-01
Address:
Marseille, Provence-Alpes-Cote D'Azur, France
Country:
France
Website Url:
http://www.neurochlore.fr
Total Employee:
11+
Status:
Active
Contact:
+33 4 84 26 90 60
Email Addresses:
[email protected]
Official Site Inspections
http://www.neurochlore.fr
- Host name: cluster028.hosting.ovh.net
- IP address: 51.91.236.193
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Neurochlore"
Recherche sur les Troubles Neurodéveloppementaux
Neurochlore ne fait plus de recherche expérimentale (animale) sur l’autisme suite à l’échec de la phase 3 : nos recherches fondamentales sont stoppées, les chercheurs, ingénieurs et techniciens ont dû quitter l’entreprise et les …See details»
Research on Neurodevelopmental Disorders
Our research aims at determining brain development alterations that lead to Autism Spectrum Disorders (ASD) and other Neurodevelopmental Disorders and identifying therapeutic targets.See details»
Clinical trials - Neurochlore
Neurochlore’s clinical trials Clinical trials with positive results on the use of Bumetanide to treat Autism have been performed on more than 120 children with Autism Spectrum Disorders …See details»
Neurochlore - Crunchbase Company Profile & Funding
Where is Neurochlore's headquarters? Neurochlore is located in Marseille, Provence-Alpes-Cote d'Azur, France. Who invested in Neurochlore? Neurochlore is funded by Incubateur Impulse. …See details»
Neurochlore - LinkedIn
Understanding and Treating Developmental Brain Disorders | The company Neurochlore is developing an innovative therapeutic strategy to ameliorate developmental brain pathologies.See details»
Yehezkel Ben-Ari - Founder and C.E.O - B&A oncomedical - LinkedIn
Yehezkel Ben-Ari is the founder of 3 companies : Neurochlore, founded in 2011 with Eric Lemonnier and Nouchine Hadjikhani (dedicated to treating Autism) , B&A oncomedical …See details»
NEUROCHLORE (MARSEILLE) Chiffre d'affaires, résultat, bilans sur ...
NEUROCHLORE, société par actions simplifiée, immatriculée sous le SIREN 533864070, est en activité depuis 13 ans. Implantée à MARSEILLE (13009), elle est spécialisée dans le secteur …See details»
Neurochlore Company Profile 2024: Valuation, Funding
Developer of a neuro-therapeutic treatment platform intended to treat autism spectrum disorders.See details»
Past Research | Neurochlore
The fundamental research carried out at Neurochlore until 2022 aimed to better understand the construction and formation of the brain during pregnancy and the first years of life, a decisive …See details»
Yehezkel BEN-ARI | CEO | PhD | Neurochlore, Marseille
Neurochlore is developing new therapeutic approaches aiming to improve neurological and psychiatric diseases treatments by the modulation of the intracellular chloride.See details»
Neurochlore | Marseille, France - ResearchGate
Find 13 researchers and browse 0 departments, publications, full-texts, contact details and general information related to Neurochlore | Marseille, France |See details»
Neurochlore Company Profile - Office Locations, Competitors
Neurochlore is a biotechnology company that specializes in treating developmental brain disorders. It offers treatment solutions for infantile epilepsies, mental retardation, genetic …See details»
NEUROCHLORE - SudPlace
NEUROCHLORE développe une stratégie thérapeutique innovante conçue pour améliorer les pathologies cérébrales développementales. Traduction automatiqueSee details»
Research on Neurodevelopmental Disorders | Neurochlore - Sur.ly
Research on Neurodevelopmental Disorders | Neurochlore. Our research aims at determining brain development alterations that lead to Autism Spectrum Disorders (ASD) and other …See details»
Recherche passée - Neurochlore
La recherche fondamentale effectuée à Neurochlore jusqu’en 2022 avait pour but de mieux comprendre la construction et formation du cerveau pendant la grossesse et les premières …See details»
Neurochlore - Products, Competitors, Financials, Employees ...
Neurochlore focuses on developing therapeutic strategies for developmental brain pathologies within the biotechnology and pharmaceutical industry. Use the CB Insights Platform to explore …See details»
Yehezkel Ben-Ari's lab | Neurochlore - ResearchGate
Nous avons développé une approche fondée sur l’analyse par machine learning des données biologiques et échographiques recueillies en routine, du début de la grossesse au lendemain …See details»
Research Facilities - Neurochlore
We compare naïve and experimental pathological models in order to determine the ionic current (s) altered that are the cause of the disorder and a possible therapeutic target.See details»
Marseille : Neurochlore lève 9 millions d'euros pour traiter l’autisme
Mar 3, 2016 · La startup marseille Neurochlore développe le premier traitement thérapeutique des troubles liés à l’autisme. Elle vient d’obtenir 9 millions d’euros de prêt convertible en actions …See details»
Latest News about Neurochlore : Updates, Press Releases, …
Sep 23, 2021 · Encourage, support and publicize active, innovative companies that create jobs in the industrial and craft fields, these are the objectives set by the General Council of Bouches …See details»